Ch Biotech R And D Co

Ch Biotech R And D Co's reported carbon emissions

CH Biotech R And D Co., a pharmaceutical preparation manufacturer headquartered in Taiwan, has reported its carbon emissions for several years. In 2025, the company's total reported emissions were approximately 3,992,683 kg CO2e. This figure includes Scope 1 emissions totalling about 430,778 kg CO2e and Scope 3 emissions of approximately 103,253 kg CO2e. Scope 2 emissions data was not disclosed for this year. For 2024, CH Biotech R And D Co. reported total emissions of around 3,749,933 kg CO2e. Scope 1 emissions for this period were approximately 360,118 kg CO2e, with Scope 3 emissions at about 97,638 kg CO2e. Scope 2 data was also not disclosed for 2024. In 2023, the company's total emissions stood at approximately 3,714,426 kg CO2e. This comprised Scope 1 emissions of about 452,459 kg CO2e, Scope 2 emissions of approximately 3,063,638 kg CO2e, and Scope 3 emissions of roughly 198,328 kg CO2e. For 2022, total emissions were approximately 3,839,712 kg CO2e, with Scope 1 emissions around 437,909 kg CO2e, Scope 2 emissions at approximately 3,260,882 kg CO2e, and Scope 3 emissions of about 140,920 kg CO2e. In 2021, CH Biotech R And D Co. reported Scope 1 emissions of about 444,390 kg CO2e, Scope 2 emissions of approximately 3,458,040 kg CO2e, and Scope 3 emissions of around 92,920 kg CO2e. CH Biotech R And D Co. has not disclosed any specific reduction targets or commitments through their provided documentation. However, their reporting indicates a commitment to tracking and disclosing emissions across various scopes within the pharmaceutical preparation manufacturing industry.